Compare ERIC & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | CAH |
|---|---|---|
| Founded | 1876 | 1979 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7B | 55.6B |
| IPO Year | 2002 | 1994 |
| Metric | ERIC | CAH |
|---|---|---|
| Price | $9.42 | $233.17 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 17 |
| Target Price | $9.33 | ★ $270.33 |
| AVG Volume (30 Days) | ★ 6.6M | 1.5M |
| Earning Date | 10-15-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.50% | 0.89% |
| EPS Growth | N/A | ★ 12.09 |
| EPS | N/A | ★ 7.23 |
| Revenue | N/A | ★ $254,248,000,000.00 |
| Revenue This Year | N/A | $4.57 |
| Revenue Next Year | $2.02 | $6.19 |
| P/E Ratio | ★ $12.13 | $32.15 |
| Revenue Growth | N/A | ★ 14.23 |
| 52 Week Low | $8.12 | $151.87 |
| 52 Week High | $13.77 | $258.30 |
| Indicator | ERIC | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 55.35 |
| Support Level | $9.25 | $227.68 |
| Resistance Level | $10.38 | $243.21 |
| Average True Range (ATR) | 0.16 | 4.95 |
| MACD | -0.06 | 0.88 |
| Stochastic Oscillator | 27.05 | 85.19 |
Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.